EHA 2024

Meet us in Madrid!

Meet BIOTYPE at the EHA 2024 congress taking place from June 13th to 16th in Madrid!

Did you know that acute myeloid leukaemia (AML) is the most common type of acute leukaemia in adults? Early, fast, and accurate diagnosis of AML and its subtype is crucial for effective patient treatment.

Our Mentype® AMLplexQS and the upcoming MODAPLEX AML Panel support the analysis of clinically relevant gene fusions or mutations in leukaemia using different technologies.

We would be delighted to arrange a meeting with you during the congress to address any questions you may have regarding the technical background of the assays, IVDR conformity or any other topics.

Schedule a meeting with Marie Helbig (Product Manager Hemato-Oncology) to discuss how our products and services can meet your needs: m.helbig@biotype.de, +49 351 8838 471